(19)
(11) EP 4 188 338 A1

(12)

(43) Date of publication:
07.06.2023 Bulletin 2023/23

(21) Application number: 21755380.9

(22) Date of filing: 23.07.2021
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/397(2006.01)
A61K 45/06(2006.01)
 A61K 9/24(2006.01)
A61K 31/40(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/397; A61K 31/40; A61K 45/06; A61K 9/2018; A61K 9/2027; A61K 9/209
 
C-Sets:
  1. A61K 31/397, A61K 2300/00;
  2. A61K 31/40, A61K 2300/00;
(86) International application number:
PCT/EP2021/070680
(87) International publication number:
WO 2022/023206 (03.02.2022 Gazette 2022/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.07.2020 SI 202000126

(71) Applicant: KRKA, d.d., Novo mesto
8000 Novo mesto (SI)

(72) Inventors:
  • VIDEC, Danijel
    1000 Ljubljana (SI)
  • BUKOVEC, Polona
    8000 Novo mesto (SI)
  • DEBELJAK SIMONCIC, Kristina
    8310 Sentjernej (SI)
  • HUDOVORNIK, Grega
    8000 Novo mesto (SI)
  • KORASA, Klemen
    1000 Ljubljana (SI)
  • OMERZU, Maja
    8270 Krsko (SI)

(74) Representative: Kutzenberger Wolff & Partner 
Waidmarkt 11
50676 Köln
50676 Köln (DE)

   


(54) BILAYER TABLET COMPRISING EZETIMIBE AND ATORVASTATIN